Literature DB >> 31377045

Regional Gray Matter Volume Links Rest-Activity Rhythm Fragmentation With Past Cognitive Decline.

Stephen F Smagula1, Lana Chahine2, Andrea Metti3, Anusha Rangarajan4, Howard J Aizenstein4, Qu Tian5, Caterina Rosano3.   

Abstract

OBJECTIVES: We examined the extent to which measures of neurodegeneration and cerebrovascular disease explain the rest-activity rhythm (RAR)-cognition link.
METHODS: Seventy participants (mean age at MRI = 86, standard deviation (SD) = 2.6; 53% female) had cognitive, MRI, and accelerometer data. The slope of cognitive decline was defined applying a mixed model to 10 repeated Modified Mini Mental Status Test (3MS) measures over 14 years. Regional gray matter volume (GMV), white matter hyperintensities, and RARs were measured around year 12.
RESULTS: Past 3MS decline was related to RAR fragmentation (per SD β = -0.43, 95% confidence interval: -0.73, -0.14) and lower posterior parietal GMV (per standard deviation β = 0.47, 95% confidence interval: 0.14, 0.79). Higher RAR fragmentation was related to lower posterior parietal GMV (Pearson r = -0.39, n = 70, p = 0.0007), which attenuated the association of RAR fragmentation and past cognitive decline by 17%.
CONCLUSIONS: Longitudinal studies are warranted to understand the temporal relations and mechanisms linking RAR fragmentation and neurodegeneration.
Copyright © 2019 American Association for Geriatric Psychiatry. All rights reserved.

Entities:  

Keywords:  Rest-activity rhythm; cerebrovascular; cognition; magnetic resonance imaging; neurodegenerative

Mesh:

Year:  2019        PMID: 31377045      PMCID: PMC6980463          DOI: 10.1016/j.jagp.2019.07.009

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  7 in total

1.  The Modified Mini-Mental State (3MS) examination.

Authors:  E L Teng; H C Chui
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

2.  Neuroimaging differences between older adults with maintained versus declining cognition over a 10-year period.

Authors:  Caterina Rosano; Howard J Aizenstein; Anne B Newman; Vijay Venkatraman; Tamara Harris; Jingzhong Ding; Suzanne Satterfield; Kristine Yaffe
Journal:  Neuroimage       Date:  2012-04-20       Impact factor: 6.556

3.  Cerebral small vessel disease is related to disturbed 24-h activity rhythms: a population-based study.

Authors:  L A Zuurbier; M A Ikram; A I Luik; A Hofman; E J W Van Someren; M W Vernooij; H Tiemeier
Journal:  Eur J Neurol       Date:  2015-07-24       Impact factor: 6.089

4.  Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.

Authors:  Erik S Musiek; Meghana Bhimasani; Margaret A Zangrilli; John C Morris; David M Holtzman; Yo-El S Ju
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

5.  Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease.

Authors:  W Witting; I H Kwa; P Eikelenboom; M Mirmiran; D F Swaab
Journal:  Biol Psychiatry       Date:  1990-03-15       Impact factor: 13.382

6.  In vivo staging of regional amyloid deposition.

Authors:  Michel J Grothe; Henryk Barthel; Jorge Sepulcre; Martin Dyrba; Osama Sabri; Stefan J Teipel
Journal:  Neurology       Date:  2017-10-18       Impact factor: 11.800

7.  'nparACT' package for R: A free software tool for the non-parametric analysis of actigraphy data.

Authors:  Christine Blume; Nayantara Santhi; Manuel Schabus
Journal:  MethodsX       Date:  2016-05-24
  7 in total
  2 in total

1.  Classification of Depressive and Schizophrenic Episodes Using Night-Time Motor Activity Signal.

Authors:  Julieta G Rodríguez-Ruiz; Carlos E Galván-Tejada; Huizilopoztli Luna-García; Hamurabi Gamboa-Rosales; José M Celaya-Padilla; José G Arceo-Olague; Jorge I Galván Tejada
Journal:  Healthcare (Basel)       Date:  2022-07-05

2.  Sleep, 24-h activity rhythms, and plasma markers of neurodegenerative disease.

Authors:  Thom S Lysen; M Arfan Ikram; Mohsen Ghanbari; Annemarie I Luik
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.